Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Depreciation and Depletion (2024 - 2025)

Cytosorbents' Depreciation and Depletion history spans 4 years, with the latest figure at $300000.0 for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $300000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (down 14.29% YoY), and the annual figure for FY2025 was $1.2 million, down 7.69%.
  • Depreciation and Depletion for Q4 2025 was $300000.0 at Cytosorbents, roughly flat from $300000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $457800.0 in Q2 2024 to a low of $294300.0 in Q2 2025.